検索対象:     
報告書番号:
※ 半角英数字
 年 ~ 
 年

Synthesis and ${{it in vitro}}$ evaluation of $$^{64}$$Cu-labeled peptide for tumor imaging

腫瘍のイメージングに有用な$$^{64}$$Cu標識ペプチドの合成と${{it in vitro}}$評価

須郷 由美; 佐々木 一郎; 渡辺 茂樹; 大島 康宏; 石岡 典子

Sugo, Yumi; Sasaki, Ichiro; Watanabe, Shigeki; Ohshima, Yasuhiro; Ishioka, Noriko

MARSGL peptide (H-Met-Ala-Arg-Ser-Gly-Leu-OH) has high affinity to the human epidermal growth factor receptor 2 (HER2) overexpressing in various tumor cells. Copper-64 ($$^{64}$$Cu) is a useful radionuclide in nuclear medicine, and can be produced by the cyclotron. In this study, we designed and synthesized $$^{64}$$Cu-labeled MARSGL peptide conjugated with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) as a novel positron emission tomography (PET) imaging probe for HER2 overexpressing tumors. The formation of $$^{64}$$Cu-DOTA-MARSGL was determined by TLC and HPLC compared with a non-radioactive preparation. It was confirmed that $$^{64}$$Cu-DOTA-MARSGL was obtained in high radiochemical yield more than 94%. We also examined a stability of $$^{64}$$Cu-DOTA-MARSGL ${it in vitro}$. The chromatogram was not changed after incubation in physiological saline at 37$$^{circ}$$C overnight. In order to evaluate the usefulness as a PET imaging probe, further ${it in vitro}$ studies on the stability in human or mice plasma and the cellular uptake are in progress.

Access

:

- Accesses

InCites™

:

Altmetrics

:

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.